News Pharma looking for progress as Brexit talks restart Pharma hoping for mutual recognition arrangement
News Last year 'worst ever' for NHS medicines shortages - expert System is breaking down across EU, conference hears
News New Teva CEO axes R&D chief Hayden in boardroom shakeup R&D chief Michael Hayden to leave at year end.
News Teva sells women's health division to tackle $35bn debts Teva has sold its women’s health business in order to pay off some of its $35 billion in debts built up in acquiring Allergan’s generics business.
News Bidders lining up for Teva women's health unit Allergan generics buyout left Teva with $35m debts
News FDA's Gottlieb reveals plans to tackle generic price abuses Tackling high drug prices is priority for Trump administrations.
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
